Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
URO-VAXOM in female patients with uncomplicated recurrent urinary tract infections
2007-004586-17Phase 3Completed
- Sponsor
- OM Pharma
- Start
- Dec 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in urinary tract infection (UTI) and uncomplicated urinary tract infection (UTI) comparing Uro-Vaxom arm with Placebo arm (2 arms). Primary endpoint: Mean rate of acute uncomplicated urinary tract infection events over 6 months. Started Dec 2007; status: completed.
02
Drugs
OM-89
03
Conditions
urinary tract infection (UTI)uncomplicated urinary tract infection (UTI)
Beyond the preview
Go deeper on 2007-004586-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004586-17.